Three Leading Weight Management Injections Compared
Wegovy v Saxenda vs Mounjaro: Active Ingredient Differences
Understanding how Wegovy v Saxenda compares to Mounjaro requires examining their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, administered once weekly via FlexTouch pen. Saxenda uses liraglutide, also a GLP-1 agonist but requiring daily injections at lower individual doses. Mounjaro represents the newest approach with tirzepatide, a dual GIP and GLP-1 receptor agonist that targets two hormone pathways simultaneously. This dual mechanism may offer different appetite control patterns, though direct head-to-head comparisons between all three haven't been conducted in the same clinical trial.
The dosing frequency distinction becomes particularly relevant when comparing Wegovy v Saxenda in your daily routine. Wegovy's once-weekly schedule follows a structured escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. Saxenda requires daily administration starting at 0.6mg, increasing weekly to a maximum 3mg daily dose. Mounjaro offers weekly dosing like Wegovy but with six available strengths from 2.5mg to 15mg, providing more granular dose adjustments for individual tolerance and effectiveness.
Pricing Comparison: Wegovy v Saxenda vs Mounjaro Costs
When evaluating Wegovy v Saxenda pricing, monthly costs vary significantly due to dosing frequency differences. Wegovy starter doses begin at £79.99 for the 0.25mg pen (4 weeks supply), progressing to £209.99 for maintenance 2.4mg pens. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25. Our Intro Duo bundle (0.25mg & 0.5mg Wegovy) costs £169.99, covering your first 8 weeks of treatment with Reliable Supply continuity.
Saxenda pricing reflects its daily dosing requirement, typically requiring multiple pens per month depending on your prescribed dose. Mounjaro weekly pens are priced competitively within the premium weight management injection category. The practical cost consideration for Wegovy v Saxenda centres on injection frequency—four weekly Wegovy injections versus up to 30 daily Saxenda injections monthly. EverydayMeds offers flexible payment options and bundle packages for all three treatments, allowing you to choose based on clinical suitability rather than purely financial constraints.
Clinical Evidence: STEP vs SCALE vs SURPASS Trials
The clinical evidence supporting Wegovy v Saxenda efficacy comes from separate trial programmes with different methodologies. Wegovy's STEP trials, including the landmark study by Wilding et al., NEJM, 2021, demonstrated that participants taking semaglutide 2.4mg weekly alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks. The STEP programme included over 4,500 participants across multiple studies, establishing Wegovy's evidence base for MHRA licensing.
Saxenda's SCALE trials evaluated liraglutide 3mg daily, showing different weight loss patterns due to the distinct dosing approach and compound properties. Mounjaro's SURPASS programme focused primarily on diabetes outcomes, with weight loss as a secondary endpoint, making direct comparisons challenging. When considering Wegovy v Saxenda clinical profiles, both demonstrate significant weight management benefits in clinical trial settings, though individual responses vary considerably based on genetic factors, adherence, and lifestyle modifications.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy's semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone naturally released by your intestinal cells after eating. This hormone signals your brain's appetite centres, promoting satiety and reducing food cravings between meals. The weekly injection maintains steady semaglutide levels, providing consistent appetite regulation compared to natural GLP-1's rapid breakdown. Clinical studies suggest Wegovy may slow gastric emptying, helping you feel fuller for longer periods after eating smaller portions. When comparing Wegovy v Saxenda mechanisms, both target GLP-1 receptors but with different pharmacokinetic profiles affecting duration and intensity of appetite suppression. The prescription-only medicine requires careful dose escalation to minimise gastrointestinal side effects whilst maximising therapeutic benefits.
EverydayMeds Ordering Process: Assessment to Delivery
Ordering Wegovy v Saxenda or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring each prescription meets MHRA safety requirements and NICE guidance criteria. Once approved, your chosen treatment ships via next-day cold-chain delivery, maintaining the precise 2-8°C temperature range required for injectable medicines. Our GPhC-registered pharmacy (#9012878) sources directly from licensed UK wholesalers, guaranteeing authentic prescription-only medicines with full regulatory compliance. Patient support continues post-delivery with dosing guidance, side effect monitoring, and ongoing prescription management through our secure online portal.
Storage and Practical Considerations for All Three Options
Storage requirements significantly impact the Wegovy v Saxenda vs Mounjaro comparison for frequent travellers or busy lifestyles. Wegovy offers superior room temperature stability—6 weeks below 30°C once removed from refrigeration—compared to Mounjaro's 21-day room temperature limit and Saxenda's shorter stability window. All three require initial refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature tolerance provides practical advantages for business travel or irregular schedules. The FlexTouch pen system used by Wegovy delivers precise doses with minimal preparation, whilst injection technique remains consistent across all three treatments. Proper disposal through local pharmacy needle return programmes ensures safe handling of these prescription-only medicines throughout your treatment journey.
Weekly vs Daily Injections: Lifestyle Impact Analysis
The fundamental difference between Wegovy v Saxenda lies in injection frequency's psychological and practical impact on treatment adherence. Weekly Wegovy injections allow for routine scheduling—many patients choose the same day each week, integrating seamlessly with existing habits like weekend meal preparation or Monday health routines. This reduced injection frequency may improve long-term adherence rates, particularly for individuals with needle anxiety or complex daily medication regimens. Research suggests that less frequent dosing correlates with better treatment persistence in chronic conditions.
Daily Saxenda injections require consistent timing and preparation, potentially offering more granular dose control but increasing the psychological burden of daily medical routines. Some patients prefer daily dosing's flexibility for timing adjustments around meals or activities. Mounjaro's weekly schedule matches Wegovy's convenience whilst providing six dose strengths for individualised titration. When evaluating Wegovy v Saxenda for your lifestyle, consider your current medication habits, travel frequency, and personal preferences regarding medical routine integration into daily life.
Start Your Weight Management Journey: Codes and Next Steps
Ready to begin comparing Wegovy v Saxenda vs Mounjaro for your individual needs? Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to explore detailed product information, pricing, and bundle options for all three treatments. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 for ongoing savings. Our clinical team stands ready to guide your treatment selection based on medical suitability, lifestyle factors, and personal preferences—remember, there's no universally "best" option, only the right choice for your circumstances. Complete your clinical assessment today to begin this medically-supervised weight management journey with the UK's trusted online pharmacy. Both Wegovy and Saxenda, alongside Mounjaro, are available from EverydayMeds—your prescriber can help determine which prescription-only medicine aligns with your health goals and medical history.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
